img

Global Drug of Abuse Screening Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Drug of Abuse Screening Market Research Report 2024

According to MRAResearch’s new survey, global Drug of Abuse Screening market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Drug of Abuse Screening market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Drug of Abuse Screening market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Abbott Laboratories, Inc.
Thermo Fisher Scientific
LabCorp (Laboratory Corporation of America)
Psychemedics Corporation
Sonic Healthcare
Bio-Rad Laboratories
Quest Diagnostics
Randox Laboratories
F. Hoffman-La Roche
Segment by Type
On-Site Screening
Laboratory-Based Screening

Segment by Application


Medical
Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Drug of Abuse Screening report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug of Abuse Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 On-Site Screening
1.2.3 Laboratory-Based Screening
1.3 Market by Application
1.3.1 Global Drug of Abuse Screening Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Medical
1.3.3 Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug of Abuse Screening Market Perspective (2018-2033)
2.2 Drug of Abuse Screening Growth Trends by Region
2.2.1 Global Drug of Abuse Screening Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Drug of Abuse Screening Historic Market Size by Region (2018-2023)
2.2.3 Drug of Abuse Screening Forecasted Market Size by Region (2024-2033)
2.3 Drug of Abuse Screening Market Dynamics
2.3.1 Drug of Abuse Screening Industry Trends
2.3.2 Drug of Abuse Screening Market Drivers
2.3.3 Drug of Abuse Screening Market Challenges
2.3.4 Drug of Abuse Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug of Abuse Screening Players by Revenue
3.1.1 Global Top Drug of Abuse Screening Players by Revenue (2018-2023)
3.1.2 Global Drug of Abuse Screening Revenue Market Share by Players (2018-2023)
3.2 Global Drug of Abuse Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug of Abuse Screening Revenue
3.4 Global Drug of Abuse Screening Market Concentration Ratio
3.4.1 Global Drug of Abuse Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug of Abuse Screening Revenue in 2022
3.5 Drug of Abuse Screening Key Players Head office and Area Served
3.6 Key Players Drug of Abuse Screening Product Solution and Service
3.7 Date of Enter into Drug of Abuse Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug of Abuse Screening Breakdown Data by Type
4.1 Global Drug of Abuse Screening Historic Market Size by Type (2018-2023)
4.2 Global Drug of Abuse Screening Forecasted Market Size by Type (2024-2033)
5 Drug of Abuse Screening Breakdown Data by Application
5.1 Global Drug of Abuse Screening Historic Market Size by Application (2018-2023)
5.2 Global Drug of Abuse Screening Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Drug of Abuse Screening Market Size (2018-2033)
6.2 North America Drug of Abuse Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Drug of Abuse Screening Market Size by Country (2018-2023)
6.4 North America Drug of Abuse Screening Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug of Abuse Screening Market Size (2018-2033)
7.2 Europe Drug of Abuse Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Drug of Abuse Screening Market Size by Country (2018-2023)
7.4 Europe Drug of Abuse Screening Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug of Abuse Screening Market Size (2018-2033)
8.2 Asia-Pacific Drug of Abuse Screening Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Drug of Abuse Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific Drug of Abuse Screening Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug of Abuse Screening Market Size (2018-2033)
9.2 Latin America Drug of Abuse Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Drug of Abuse Screening Market Size by Country (2018-2023)
9.4 Latin America Drug of Abuse Screening Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug of Abuse Screening Market Size (2018-2033)
10.2 Middle East & Africa Drug of Abuse Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Drug of Abuse Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa Drug of Abuse Screening Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories, Inc.
11.1.1 Abbott Laboratories, Inc. Company Detail
11.1.2 Abbott Laboratories, Inc. Business Overview
11.1.3 Abbott Laboratories, Inc. Drug of Abuse Screening Introduction
11.1.4 Abbott Laboratories, Inc. Revenue in Drug of Abuse Screening Business (2018-2023)
11.1.5 Abbott Laboratories, Inc. Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Drug of Abuse Screening Introduction
11.2.4 Thermo Fisher Scientific Revenue in Drug of Abuse Screening Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 LabCorp (Laboratory Corporation of America)
11.3.1 LabCorp (Laboratory Corporation of America) Company Detail
11.3.2 LabCorp (Laboratory Corporation of America) Business Overview
11.3.3 LabCorp (Laboratory Corporation of America) Drug of Abuse Screening Introduction
11.3.4 LabCorp (Laboratory Corporation of America) Revenue in Drug of Abuse Screening Business (2018-2023)
11.3.5 LabCorp (Laboratory Corporation of America) Recent Development
11.4 Psychemedics Corporation
11.4.1 Psychemedics Corporation Company Detail
11.4.2 Psychemedics Corporation Business Overview
11.4.3 Psychemedics Corporation Drug of Abuse Screening Introduction
11.4.4 Psychemedics Corporation Revenue in Drug of Abuse Screening Business (2018-2023)
11.4.5 Psychemedics Corporation Recent Development
11.5 Sonic Healthcare
11.5.1 Sonic Healthcare Company Detail
11.5.2 Sonic Healthcare Business Overview
11.5.3 Sonic Healthcare Drug of Abuse Screening Introduction
11.5.4 Sonic Healthcare Revenue in Drug of Abuse Screening Business (2018-2023)
11.5.5 Sonic Healthcare Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Detail
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Drug of Abuse Screening Introduction
11.6.4 Bio-Rad Laboratories Revenue in Drug of Abuse Screening Business (2018-2023)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 Quest Diagnostics
11.7.1 Quest Diagnostics Company Detail
11.7.2 Quest Diagnostics Business Overview
11.7.3 Quest Diagnostics Drug of Abuse Screening Introduction
11.7.4 Quest Diagnostics Revenue in Drug of Abuse Screening Business (2018-2023)
11.7.5 Quest Diagnostics Recent Development
11.8 Randox Laboratories
11.8.1 Randox Laboratories Company Detail
11.8.2 Randox Laboratories Business Overview
11.8.3 Randox Laboratories Drug of Abuse Screening Introduction
11.8.4 Randox Laboratories Revenue in Drug of Abuse Screening Business (2018-2023)
11.8.5 Randox Laboratories Recent Development
11.9 F. Hoffman-La Roche
11.9.1 F. Hoffman-La Roche Company Detail
11.9.2 F. Hoffman-La Roche Business Overview
11.9.3 F. Hoffman-La Roche Drug of Abuse Screening Introduction
11.9.4 F. Hoffman-La Roche Revenue in Drug of Abuse Screening Business (2018-2023)
11.9.5 F. Hoffman-La Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Drug of Abuse Screening Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of On-Site Screening
Table 3. Key Players of Laboratory-Based Screening
Table 4. Global Drug of Abuse Screening Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Drug of Abuse Screening Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Drug of Abuse Screening Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Drug of Abuse Screening Market Share by Region (2018-2023)
Table 8. Global Drug of Abuse Screening Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Drug of Abuse Screening Market Share by Region (2024-2033)
Table 10. Drug of Abuse Screening Market Trends
Table 11. Drug of Abuse Screening Market Drivers
Table 12. Drug of Abuse Screening Market Challenges
Table 13. Drug of Abuse Screening Market Restraints
Table 14. Global Drug of Abuse Screening Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Drug of Abuse Screening Market Share by Players (2018-2023)
Table 16. Global Top Drug of Abuse Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse Screening as of 2022)
Table 17. Ranking of Global Top Drug of Abuse Screening Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Drug of Abuse Screening Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Drug of Abuse Screening Product Solution and Service
Table 21. Date of Enter into Drug of Abuse Screening Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug of Abuse Screening Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Drug of Abuse Screening Revenue Market Share by Type (2018-2023)
Table 25. Global Drug of Abuse Screening Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Drug of Abuse Screening Revenue Market Share by Type (2024-2033)
Table 27. Global Drug of Abuse Screening Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Drug of Abuse Screening Revenue Market Share by Application (2018-2023)
Table 29. Global Drug of Abuse Screening Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Drug of Abuse Screening Revenue Market Share by Application (2024-2033)
Table 31. North America Drug of Abuse Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Drug of Abuse Screening Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Drug of Abuse Screening Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Drug of Abuse Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Drug of Abuse Screening Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Drug of Abuse Screening Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Drug of Abuse Screening Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Drug of Abuse Screening Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Drug of Abuse Screening Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Drug of Abuse Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Drug of Abuse Screening Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Drug of Abuse Screening Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Drug of Abuse Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Drug of Abuse Screening Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Drug of Abuse Screening Market Size by Country (2024-2033) & (US$ Million)
Table 46. Abbott Laboratories, Inc. Company Detail
Table 47. Abbott Laboratories, Inc. Business Overview
Table 48. Abbott Laboratories, Inc. Drug of Abuse Screening Product
Table 49. Abbott Laboratories, Inc. Revenue in Drug of Abuse Screening Business (2018-2023) & (US$ Million)
Table 50. Abbott Laboratories, Inc. Recent Development
Table 51. Thermo Fisher Scientific Company Detail
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Drug of Abuse Screening Product
Table 54. Thermo Fisher Scientific Revenue in Drug of Abuse Screening Business (2018-2023) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. LabCorp (Laboratory Corporation of America) Company Detail
Table 57. LabCorp (Laboratory Corporation of America) Business Overview
Table 58. LabCorp (Laboratory Corporation of America) Drug of Abuse Screening Product
Table 59. LabCorp (Laboratory Corporation of America) Revenue in Drug of Abuse Screening Business (2018-2023) & (US$ Million)
Table 60. LabCorp (Laboratory Corporation of America) Recent Development
Table 61. Psychemedics Corporation Company Detail
Table 62. Psychemedics Corporation Business Overview
Table 63. Psychemedics Corporation Drug of Abuse Screening Product
Table 64. Psychemedics Corporation Revenue in Drug of Abuse Screening Business (2018-2023) & (US$ Million)
Table 65. Psychemedics Corporation Recent Development
Table 66. Sonic Healthcare Company Detail
Table 67. Sonic Healthcare Business Overview
Table 68. Sonic Healthcare Drug of Abuse Screening Product
Table 69. Sonic Healthcare Revenue in Drug of Abuse Screening Business (2018-2023) & (US$ Million)
Table 70. Sonic Healthcare Recent Development
Table 71. Bio-Rad Laboratories Company Detail
Table 72. Bio-Rad Laboratories Business Overview
Table 73. Bio-Rad Laboratories Drug of Abuse Screening Product
Table 74. Bio-Rad Laboratories Revenue in Drug of Abuse Screening Business (2018-2023) & (US$ Million)
Table 75. Bio-Rad Laboratories Recent Development
Table 76. Quest Diagnostics Company Detail
Table 77. Quest Diagnostics Business Overview
Table 78. Quest Diagnostics Drug of Abuse Screening Product
Table 79. Quest Diagnostics Revenue in Drug of Abuse Screening Business (2018-2023) & (US$ Million)
Table 80. Quest Diagnostics Recent Development
Table 81. Randox Laboratories Company Detail
Table 82. Randox Laboratories Business Overview
Table 83. Randox Laboratories Drug of Abuse Screening Product
Table 84. Randox Laboratories Revenue in Drug of Abuse Screening Business (2018-2023) & (US$ Million)
Table 85. Randox Laboratories Recent Development
Table 86. F. Hoffman-La Roche Company Detail
Table 87. F. Hoffman-La Roche Business Overview
Table 88. F. Hoffman-La Roche Drug of Abuse Screening Product
Table 89. F. Hoffman-La Roche Revenue in Drug of Abuse Screening Business (2018-2023) & (US$ Million)
Table 90. F. Hoffman-La Roche Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug of Abuse Screening Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Drug of Abuse Screening Market Share by Type: 2022 VS 2033
Figure 3. On-Site Screening Features
Figure 4. Laboratory-Based Screening Features
Figure 5. Global Drug of Abuse Screening Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Drug of Abuse Screening Market Share by Application: 2022 VS 2033
Figure 7. Medical Case Studies
Figure 8. Research Case Studies
Figure 9. Drug of Abuse Screening Report Years Considered
Figure 10. Global Drug of Abuse Screening Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Drug of Abuse Screening Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Drug of Abuse Screening Market Share by Region: 2022 VS 2033
Figure 13. Global Drug of Abuse Screening Market Share by Players in 2022
Figure 14. Global Top Drug of Abuse Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse Screening as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Drug of Abuse Screening Revenue in 2022
Figure 16. North America Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Drug of Abuse Screening Market Share by Country (2018-2033)
Figure 18. United States Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Drug of Abuse Screening Market Share by Country (2018-2033)
Figure 22. Germany Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Drug of Abuse Screening Market Share by Region (2018-2033)
Figure 30. China Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Drug of Abuse Screening Market Share by Country (2018-2033)
Figure 38. Mexico Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Drug of Abuse Screening Market Share by Country (2018-2033)
Figure 42. Turkey Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Abbott Laboratories, Inc. Revenue Growth Rate in Drug of Abuse Screening Business (2018-2023)
Figure 45. Thermo Fisher Scientific Revenue Growth Rate in Drug of Abuse Screening Business (2018-2023)
Figure 46. LabCorp (Laboratory Corporation of America) Revenue Growth Rate in Drug of Abuse Screening Business (2018-2023)
Figure 47. Psychemedics Corporation Revenue Growth Rate in Drug of Abuse Screening Business (2018-2023)
Figure 48. Sonic Healthcare Revenue Growth Rate in Drug of Abuse Screening Business (2018-2023)
Figure 49. Bio-Rad Laboratories Revenue Growth Rate in Drug of Abuse Screening Business (2018-2023)
Figure 50. Quest Diagnostics Revenue Growth Rate in Drug of Abuse Screening Business (2018-2023)
Figure 51. Randox Laboratories Revenue Growth Rate in Drug of Abuse Screening Business (2018-2023)
Figure 52. F. Hoffman-La Roche Revenue Growth Rate in Drug of Abuse Screening Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed